BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38434975)

  • 1. Lycorine inhibits migration and proliferation of hepatocellular carcinoma cells by reducing transketonase expression.
    Ge LL; Wang H; Zhang YH; Wang HJ; Li L
    J Cancer; 2024; 15(7):1826-1836. PubMed ID: 38434975
    [No Abstract]   [Full Text] [Related]  

  • 2. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
    Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
    Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
    Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dealcoholized red wine inhibits occurrence and progression of hepatocellular carcinoma possibly by inducing cell cycle arrest and apoptosis].
    Lan Y; Wang K; Lan Z; Zhou H; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1297-1305. PubMed ID: 37712265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.
    Geng L; Zhu M; Luo D; Chen H; Li B; Lao Y; An H; Wu Y; Li Y; Xia A; Shi Y; Tong Z; Lu S; Xu D; Wang X; Zhang W; Sun B; Xu Z
    Oncogene; 2024 Feb; 43(9):682-692. PubMed ID: 38216672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
    Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
    Yao J; Fu J; Liu Y; Qu W; Wang G; Yan Z
    Ann Hepatol; 2021; 23():100297. PubMed ID: 33346094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of RSPH14 inhibits proliferation, migration, and invasion and promotes apoptosis of hepatocellular carcinoma via RelA.
    Yuan D; Ma R; Sun T; Zhu K; Dang C; Ye H; Li K
    Cancer Cell Int; 2022 Mar; 22(1):129. PubMed ID: 35305640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells.
    Huang X; Xiang L; Wang B; Hu J; Liu C; Ren A; Du K; Ye G; Liang Y; Tang Y; Yang D; Yuan Y
    J Transl Med; 2021 Mar; 19(1):120. PubMed ID: 33757532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
    Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
    J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.
    Zhang J; Lin XT; Yu HQ; Fang L; Wu D; Luo YD; Zhang YJ; Xie CM
    Exp Mol Med; 2023 Oct; 55(10):2162-2176. PubMed ID: 37653031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
    Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
    Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.